Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Tailor Your Cell Culture Platform to Achieve Objectives & Scale Requirements Ann Rossi Bilodeau, Senior Bioprocess Applications Scientist, Corning Life Sciences The cell and gene therapy field is rapidly advancing, placing a focus on manufacturing challenges to meet the growing demand. The efficient harvest of... 5 days ago | 24 mins Extending Hope: Broadening Access to CAR T-Cell Therapies Ayesha A. Pandit, M.D., M.S., MBA Vice President Oncology and Hematology Medical Affairs CAR T-cell therapies have transformed the therapeutic landscape for hematologic malignancies, offering substantial benefit to patients with few altern... 2 weeks ago | 40 mins Technologies and Platform Approach for Optimizing Downstream Purification... Ashish Saksule at Vertex Pharmaceuticals and Dr Alejandro Becerra at Thermo Fisher Scientific Full title: Technologies and Platform Approach for Optimizing Downstream Purification of Viral Vectors The promising success stories and advancement ... 4 weeks ago | 103 mins A Beginner’s Guide to Scaling Up Cells Tom Bongiorno, Ph.D., Field Application Scientist, Corning Life Sciences Cell and gene therapies are typically developed using cells grown in a small-scale format, such as a well plate or T-flask. To bring such therapies th... 2 months ago | 30 mins Global Regulatory Landscape and Indian Regulatory Framework of Car-T Therapies Presented by Yogananth Rajendran at Imuneel Therapeutics Private Limited Presented by Yogananth Rajendran, M. Pharm. RAC. Head - Regulatory Affairs and Quality Assurance (Cell and Gene therapy) at Immuneel Therapeutics The... July 14, 2023 8:30am Extending Hope: Broadening Access to CAR T-Cell Therapies Ayesha A. Pandit, M.D., M.S., MBA Vice President Oncology and Hematology Medical Affairs CAR T-cell therapies have transformed the therapeutic landscape for hematologic malignancies, offering substantial benefit to patients with few altern... 1 month ago | 40 mins Quality and Compliance Requirements For Cell and Gene Therapy Products Sanjay Pandey, CAR-T, QA & Regulatory lead, Immuneel Therapeutics This presentation will outline Quality and Compliance Requirements For Cell and Gene Therapy Products which incudes”: - Facility compliance - GMP qu... October 2, 2023 8:30am Characterization of Residual Impurities in Gene Therapy Drug Products Jessica Townsend, at Intellia Therapeutics Eric S. Bishop, at Cygnus Technologies Characterization of residual impurities for gene therapy drug products is particularly challenging due to the complex nature of the final products as ... 4 months ago | 84 mins Gene Therapy 2.0: Leveraging Transgene Cassette Engineering Ben Josey, PhD, Corning Life Sciences, and Gabriela Denning, PhD, Expression Therapeutics LLC Novel gene therapies are entering the clinic and generating clinical data readouts at an unprecedented rate. As with any new therapy, the key readouts... 5 months ago | 65 mins Demonstrating Analytical Comparability in Analytical Development Santoshkumar Khatwani at Sangamo Therapeutics and James Wilkinson at Refyn The presentation will focus on challenges in analytical comparability for gene therapy products. In addition, orthogonal methods along with some of th... 4 months ago | 86 mins Load more
